BDBM50303044 (S)-3-(1-(5-fluoropyridin-2-yl)ethylamino)-5-(5-methyl-1H-pyrazol-3-ylamino)pyrazine-2-carbonitrile::CHEMBL576257

SMILES Cc1cc(Nc2cnc(C#N)c(N[C@@H](C)c3ccc(F)cn3)n2)[nH]n1

InChI Key InChIKey=KJMALBRUCRDMTE-UHFFFAOYSA-N

Data  9 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 9 hits for monomerid = 50303044   

TargetTyrosine-protein kinase JAK2(Human)
AstraZeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50303044BDBM50303044((S)-3-(1-(5-fluoropyridin-2-yl)ethylamino)-5-(5-me...)
Affinity DataIC50: 3nMAssay Description:Inhibition of JAK2 using 2 mM ATP as a substrateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
AstraZeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50303044BDBM50303044((S)-3-(1-(5-fluoropyridin-2-yl)ethylamino)-5-(5-me...)
Affinity DataIC50: 3nMAssay Description:Inhibition of JAK2 using 2 mM ATP as a substrateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
AstraZeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50303044BDBM50303044((S)-3-(1-(5-fluoropyridin-2-yl)ethylamino)-5-(5-me...)
Affinity DataIC50: 3nMAssay Description:Inhibition of JAK2 using 2 mM ATP as a substrateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
AstraZeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50303044BDBM50303044((S)-3-(1-(5-fluoropyridin-2-yl)ethylamino)-5-(5-me...)
Affinity DataIC50: 5nMAssay Description:Inhibition of JAK2 using 5 mM ATP as a substrateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetCyclin-dependent kinase 2(Human)
AstraZeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50303044BDBM50303044((S)-3-(1-(5-fluoropyridin-2-yl)ethylamino)-5-(5-me...)
Affinity DataIC50: 30nMAssay Description:Inhibition of CDK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetHigh affinity nerve growth factor receptor(Human)
AstraZeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50303044BDBM50303044((S)-3-(1-(5-fluoropyridin-2-yl)ethylamino)-5-(5-me...)
Affinity DataIC50: 670nMAssay Description:Inhibition of TRKAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetAurora kinase B(Human)
AstraZeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50303044BDBM50303044((S)-3-(1-(5-fluoropyridin-2-yl)ethylamino)-5-(5-me...)
Affinity DataIC50: 680nMAssay Description:Inhibition of Aurora BMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
AstraZeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50303044BDBM50303044((S)-3-(1-(5-fluoropyridin-2-yl)ethylamino)-5-(5-me...)
Affinity DataIC50: 5.17E+3nMAssay Description:Inhibition of JAK3 using 5 mM ATP as a substrateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
AstraZeneca

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50303044BDBM50303044((S)-3-(1-(5-fluoropyridin-2-yl)ethylamino)-5-(5-me...)
Affinity DataIC50: 1.28E+4nMAssay Description:Inhibition of JAK3 using 5 mM ATP as a substrateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2010
Entry Details Article
PubMed